Announce Date | 07/10/2025 |
EPS Normalized Actual | $2.1 (Beat by $0.04) |
EPS GAAP Actual | $2.1 (Beat by $0.04) |
Revenue Actual | $16.648B |
Revenue Surprise | Beat by $16648M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.665 |
EPS GAAP Estimate | $2.665 |
Revenue Estimate | $16.27B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 11.20956 | 4.79 | 10.61898 | 11.65623 | 3 |
Dec 2027 | 9.76716 | 5.49 | 9.50374 | 10.30936 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.29 | 0.635 | 16.648B | -0.06% | 493.65M |
FQ1 2025 (Mar 2025) | 0.37 | -0.27 | 14.04B | 2.08% | 880M |
FQ4 2024 (Dec 2024) | 1.31 | 1.31 | 15.559B | 8.59% | 15559M |
FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 15.677B | 1.21% | 15677M |
FQ2 2024 (Jun 2024) | 2.04 | 2.04 | 16.658B | 6.48% | 16658M |
FQ1 2024 (Mar 2024) | 0.32 | 0.32 | 13.748B | 7.19% | 13748M |
FQ4 2023 (Dec 2023) | 3.19 | 3.19 | 14.223B | 100% | 14223M |
FQ3 2023 (Sep 2023) | 1.73 | 1.73 | 15.488B | 9.77% | 15488M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.665
Consensus Revenue Estimates
16.27B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.93 | -- | 1.93 | 1.93 | 8 |
FQ3 2027 (Sep 2027) | 1.87 | -- | 1.87 | 1.87 | 13 |
FQ2 2027 (Jun 2027) | 2.58 | -- | 2.58 | 2.58 | 8 |
FQ1 2027 (Mar 2027) | 0.74 | -- | 0.74 | 0.74 | 8 |
FQ4 2026 (Oct 2026) | 2.66 | -- | 2.56398 | 2.73018 | 7 |
FQ3 2026 (Jul 2026) | 3 | -- | 2.89171 | 3.07915 | 4 |
FQ2 2026 (Jun 2026) | 3.3778 | 2.6 | 3.23687 | 3.65881 | 4 |
FQ1 2026 (Mar 2026) | 0.9277 | 60.12 | 0.889 | 1.00488 | 4 |
FQ4 2025 (Oct 2025) | 2.505 | 47.7 | 2.41458 | 2.57109 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 16.35B | -- | 16.35B | 16.35B | 3 |
FQ3 2027 (Sep 2027) | 16.63B | -- | 16.63B | 16.63B | 3 |
FQ2 2027 (Jun 2027) | 17.32B | -- | 17.32B | 17.32B | 3 |
FQ1 2027 (Mar 2027) | 14.43B | -- | 14.43B | 14.43B | 3 |
FQ4 2026 (Oct 2026) | 16.81B | -- | 16.35B | 17.16B | 4 |
FQ3 2026 (Jul 2026) | 16.93B | -- | 16.46B | 17.27B | 6 |
FQ2 2026 (Jun 2026) | 16.88B | 1.39 | 16.34B | 17.96B | 6 |
FQ1 2026 (Mar 2026) | 13.34B | -5.24 | 12.91B | 14.2B | 4 |
FQ4 2025 (Oct 2025) | 16.17B | 3.77 | 15.72B | 16.5B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.655 | 3.29 | 0.635 | 19.3% |
FQ1 2025 (Mar 2025) | 0.64 | 0.37 | -0.27 | -72.97% |
FQ4 2024 (Dec 2024) | 1.31 | 1.31 | 100% | |
FQ3 2024 (Sep 2024) | 1.98 | 1.98 | 100% | |
FQ2 2024 (Jun 2024) | 2.04 | 2.04 | 100% | |
FQ1 2024 (Mar 2024) | 0.32 | 0.32 | 100% | |
FQ4 2023 (Dec 2023) | 3.19 | 3.19 | 100% | |
FQ3 2023 (Sep 2023) | 1.73 | 1.73 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $16.15B | $16.65B | $493.65M | 2.97% |
FQ1 2025 (Mar 2025) | $13.16B | $14.04B | $880M | 6.27% |
FQ4 2024 (Dec 2024) | $0B | $15.56B | $15559M | 100% |
FQ3 2024 (Sep 2024) | $0B | $15.68B | $15677M | 100% |
FQ2 2024 (Jun 2024) | $0B | $16.66B | $16658M | 100% |
FQ1 2024 (Mar 2024) | $0B | $13.75B | $13748M | 100% |
FQ4 2023 (Dec 2023) | $0B | $14.22B | $14223M | 100% |
FQ3 2023 (Sep 2023) | $0B | $15.49B | $15488M | 100% |